Insider plans sale of 3,450 Class A shares

ACN insider Manish Sharma filed a notice of proposed sale under Rule 144 for up to 3,450 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of 860,568.00.

Rhea-AI Filing Summary

ACN insider Manish Sharma filed a notice of proposed sale under Rule 144 for up to 3,450 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of 860,568.00. The shares come from a stock award dated 02/01/2026.

During the prior three months, Sharma also sold 2,731 Class A Ordinary shares on 01/14/2026 for gross proceeds of 786,870.47. The filing includes a representation that the seller is not aware of undisclosed material adverse information about the issuer.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the ACN Form 144 filing disclose about upcoming share sales?

The Form 144 shows Manish Sharma intends to sell up to 3,450 Class A Ordinary shares through UBS Financial Services on the NYSE, with an aggregate market value of 860,568.00, based on a stock award received on 02/01/2026.

How many ACN shares did Manish Sharma sell in the last three months?

The filing reports that Manish Sharma sold 2,731 Class A Ordinary shares on 01/14/2026, generating gross proceeds of 786,870.47, and lists this as prior activity in the three months preceding the current planned Rule 144 sale.

What class of ACN securities is covered by this Form 144 notice?

The notice covers Class A Ordinary shares of the issuer. It specifies a proposed sale of 3,450 Class A Ordinary shares, identifies UBS Financial Services as broker, and notes trading on the NYSE, with an aggregate market value of 860,568.00 for this block.

What is the approximate sale date and exchange for the ACN Form 144 shares?

The filing lists an approximate sale date of 02/03/2026 for the 3,450 Class A Ordinary shares. It identifies the New York Stock Exchange (NYSE) as the securities exchange where these shares are expected to be sold via UBS Financial Services.

What representation does the seller make in the ACN Form 144 filing?

The seller represents that they do not know any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed, as required by the Form 144 notice language for the planned Rule 144 share sale.

How were the ACN shares in the planned Rule 144 sale originally acquired?

The Form 144 states the 3,450 Class A Ordinary shares were acquired on 02/01/2026 through a stock award from the issuer. The table lists the acquisition as a stock award transaction, with the same date also shown as the date of payment.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:02 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001911109
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	Accenture plc
SEC File Number	001-34448
Address of Issuer	1 GRAND CANAL SQUARE GRAND CANAL HARBOUR DUBLIN IRELAND D2
Phone	353-1-646-2000
Name of Person for Whose Account the Securities are To Be Sold	Sharma Manish
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Class A Ordinary	UBS Financial Services, Inc. 11 Madison Ave 4th Floor New York NY 10010	3450	860568.00	660432542	02/03/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Class A Ordinary	02/01/2026	Stock Award	Issuer			3450	02/01/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Manish Sharma c/o 1 GRAND CANAL SQUARE GRAND CANAL HARBOUR Dublin L2 D2	Class A Ordinary	01/14/2026	2731	786870.47

144: Remarks and Signature

Remarks
Date of Notice	02/03/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	06/24/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ UBS Financial Services Inc, as attorney-in-fact for Manish Sharma
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)